Phase Ib study of safety, tolerability, and efficacy of R1507 a monoclonal antibody to IGF-1R in combination with multiple standard chemotherapy regimens in patients with advanced solid malignancies.
Daruka Mahadevan
No relevant relationships to disclose
Gregory Ryan Sutton
No relevant relationships to disclose
Rafael Arteta-Bulos
No relevant relationships to disclose
Chris J. Bowden
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Paul J. E. Miller
No relevant relationships to disclose
Rachel Elizabeth Swart
Honoraria - Genentech/Roche
Research Funding - Genentech/Roche
Mark S. Walker
Consultant or Advisory Role - Genentech
Pamela N. Munster
Research Funding - Genentech/Roche
Elizabeth Claire Dees
Research Funding - Genentech/Roche
John Marshall
Consultant or Advisory Role - Genentech/Roche
Honoraria - Genentech/Roche
Research Funding - Genentech/Roche
Omid Hamid
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Razelle Kurzrock
Research Funding - Genentech/Roche